Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

• Pooja P. Pungaliya ,

  * E-mail: pooja.pungaliya@pfizer.com

  Affiliation Global Biotherapeutic Technologies, Pfizer Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Yuchen Bai,

  Current address: Center of Innovative Biology and Biotherapeutics, Pfizer Incorporated, Pearl River, New York, United States of America

  Affiliation Global Biotherapeutic Technologies, Pfizer Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Kerri Lipinski,

  Affiliation Neuroscience Research Unit, Pfizer Incorporated, Princeton, New Jersey, United States of America

  ⨯
• Vasanti S. Anand,

  Affiliation Neuroscience Research Unit, Pfizer Incorporated, Princeton, New Jersey, United States of America

  ⨯
• Saurabh Sen,

  Affiliation Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Eugene L. Brown,

  Current address: Quicksilver Consultants, Newton Highlands, Massachusetts, United States of America

  Affiliation Global Biotherapeutic Technologies, Pfizer Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Brian Bates,

  Affiliation Global Biotherapeutic Technologies, Pfizer Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Peter H. Reinhart,

  Current address: Proteostasis Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliation Neuroscience Research Unit, Pfizer Incorporated, Princeton, New Jersey, United States of America

  ⨯
• Andrew B. West,

  Affiliation Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Warren D. Hirst,

  Current address: Neuroscience Research Unit, Pfizer Incorporated, Groton, Connecticut, United States of America

  Affiliation Neuroscience Research Unit, Pfizer Incorporated, Princeton, New Jersey, United States of America

  ⨯
• Steven P. Braithwaite

  Current address: Signum Biosciences, Monmouth Junction, New Jersey, United States of America

  Affiliation Neuroscience Research Unit, Pfizer Incorporated, Princeton, New Jersey, United States of America

  ⨯